Bottom line
SHPAX vs FBT: the short answer
SHPAX (Health & Biotechnology Portfolio) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are both mutual funds.
FBT is cheaper at 0.55% vs 3% — a difference of $245 a year per $10,000 invested.
Over five years, FBT returned +4.3% a year vs +3.1% for SHPAX (reporting dates differ).
SHPAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SHPAX vs FBT side by side
| SHPAX | FBT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Saratoga Advantage | First Trust |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 3% | 0.55% |
| Annual cost per $10k | $300 | $55 |
| 10-yr cost on $10k (prospectus) | $3,702 | — |
| Max front load | 5.75% | None |
| 12b-1 fee | — | 0% |
| 1-yr return | −5.5% | +24.1% |
| 5-yr return (annualized) | +3.1% | +4.3% |
| 10-yr return (annualized) | +4.1% | +6.3% |
| Best quarter | +15.0% | +27.8% |
| Worst quarter | −13.0% | −22.5% |
| Net assets (fund) | $10.5M | $2.8B |
| Number of holdings | 29 | 32 |
| Portfolio turnover | 22% | 37% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHPAX | FBT | Difference |
|---|---|---|---|
| 2024 | +0.3% | +5.8% | −5.5% |
| 2023 | −0.4% | +2.3% | −2.6% |
| 2022 | +2.0% | −4.6% | +6.6% |
| 2021 | +16.7% | −3.6% | +20.3% |
| 2020 | +3.6% | +12.9% | −9.3% |
| 2019 | +16.2% | +19.8% | −3.6% |
| 2018 | −5.5% | −0.2% | −5.3% |
| 2017 | +12.0% | +37.0% | −25.0% |
| 2016 | −2.0% | −19.6% | +17.6% |
Source: Fund prospectus bar charts
Holdings overlap
5 of SHPAX's top 25 holdings also appear in FBT's top 25.
| Holding | SHPAX | FBT |
|---|---|---|
| United Therapeutics Corp | 6.17% | 2.56% |
| Amgen Inc | 5.04% | 2.78% |
| Exelixis Inc | 4.55% | 3.32% |
| Vertex Pharmaceuticals Inc | 3.36% | 3.07% |
| Incyte Corp | 2.89% | 3.18% |
Source: SEC Form N-PORT
SHPAX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
FAQ
What is the difference between SHPAX and FBT?
Which is cheaper, SHPAX or FBT?
Should I own both SHPAX and FBT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.